What are the target levels for Thyroid-Stimulating Hormone (TSH) in the third trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Target TSH Levels in Pregnancy

The target levels for Thyroid-Stimulating Hormone (TSH) in the third trimester of pregnancy are:

  • ≤3 mIU/L, as recommended by recent guidelines 1
  • Greater than 2·5 mIU/L in the first trimester and greater than 3 mIU/L in the second and third trimesters, as defined by some authors 2

Key Findings

  • A study found that 46% of levothyroxine-treated women had a TSH level greater than 2.5 mU/L, with 7.4% greater than 10 mU/L 3
  • Women with TSH greater than 2.5 mU/L in the first trimester had an increased risk of miscarriage compared with women with TSH 0.2-2.5 mU/L 3
  • The majority of women with hypothyroidism do not achieve the recommended preconception and early gestation TSH targets 4

TSH Levels and Pregnancy Outcomes

  • TSH levels above 2.5 mU/L were not associated with adverse fetal and maternal outcomes in one study 4
  • However, another study found that women with TSH greater than 2.5 mU/L in the first trimester had an increased risk of miscarriage 3
  • The risk of miscarriage was increased in women with TSH 4.51-10 mU/L and TSH greater than 10 mU/L, but not with TSH 2.51-4.5 mU/L 3

References

Research

Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy.

Thyroid : official journal of the American Thyroid Association, 2013

Research

Hypothyroidism in pregnancy.

The lancet. Diabetes & endocrinology, 2013

Research

TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study.

The Journal of clinical endocrinology and metabolism, 2014

Research

Preconception thyroid-stimulating hormone and pregnancy outcomes in women with hypothyroidism.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.